Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Pain
Clinical narrative: Tested positive for Covid-19 after receiving Pfizer Covid-19 vaccines/sore throat and running nose and real bad dry cough; Tested positive for Covid-19 after receiving Pfizer Covid-19 vaccines/sore throat and running nose and real bad dry cough; This is a spontaneous report received from a contactable reporter (Nurse). The reporter is the patient.  A 57-year-old female patient received BNT162b2 (BNT162B2), on 28Jul2021 at 12:00 as dose 1, 0.3 ml single (Lot number: EW0150, Expiration Date: Jul2021), in left deltoid and on 18Aug2021 as dose 2, 0.3 ml single (Lot number: EW0169, Expiration Date: Aug2021) at the age of 56 years, in left deltoid for COVID-19 immunisation. The patient's relevant medical history included: "diabetes" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "compromised immune status" (unspecified if ongoing); "respiratory illness" (unspecified if ongoing); "genetic/chromosomal abnormalities" (unspecified if ongoing); "endocrine abnormalities" (unspecified if ongoing). Concomitant medication(s) included: ROSUVASTATIN. Past drug history included: Lisinopril for high blood pressure; Atenolol for high blood pressure; Nifedipine for high blood pressure. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 09Aug2022, outcome "unknown" and all described as "Tested positive for Covid-19 after receiving Pfizer Covid-19 vaccines/sore throat and running nose and real bad dry cough". The events "tested positive for covid-19 after receiving pfizer covid-19 vaccines/sore throat and running nose and real bad dry cough" required physician office visit. The patient underwent the following laboratory tests and procedures: Chest X-ray: (unspecified date) Normal; CSF culture: (unspecified date) Normal; Culture: (unspecified date) Normal; Magnetic resonance imaging: (unspecified date) Normal; SARS-CoV-2 test: (unspecified date) Negative; (09Aug2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 included PF-07321332, ritonavir (PAXLOVID). Clinical course: she worked on Tuesday (09Aug2022) and Thursday (11Aug2022) and tested on Tuesday (09Aug2022) and Wednesday (10Aug2022) was her day off and had sore throat and running nose and real bad dry cough and she thought was strep throat and they did a rapid Covid test was negative and she was diagnosed having bronchitis as they assessed her. She was given ceftriaxone sodium (ROCEPHIN) 1g IM and a steroid and she said deco and she is unsure of which steroid and she was prescribed levofloxacin (LEVAQUIN) 500 mg once a day for 7 days. She got home had received a message from the Employee health Nurse to call back and the COVID test on Tuesday 09Aug2022 and said she has COVID and she called the doctors office and she had a video appointment and they prescribed PF-07321332, ritonavir.; Sender's Comments: Vaccination failure depends on many factors including pharmacokinetics, the pandemic and patient general health condition. However on conservative basis, the possible causality cannot be excluded.